APO RESEARCH · REPORT
Closed Drug Transfer Systems
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
Product & engineering
Understand the product.
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
Selected research
Market Structure
Global Closed Drug Transfer Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
North America is the largest Closed Drug Transfer Systems market with about 73% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are BD Medical, Inc, Equashield, LLC, ICU Medical, Inc, Teva Medical Ltd, Corvida Medical etc. Top 3 companies occupied about 74% market share.
Report Includes
Read the full market overview
This report provides an overview of the global Closed Drug Transfer Systems market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Closed Drug Transfer Systems and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Closed Drug Transfer Systems revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Closed Drug Transfer Systems market size, projected growth trends, production technologies, key applications, and end-use industries.
Closed Drug Transfer Systems Segment by Company
BD Medical, Inc
Equashield, LLC
ICU Medical, Inc
Teva Medical Ltd
Corvida Medical
Closed Drug Transfer Systems Segment by Type
Closed Vial Access Devices
Closed Syringe Safety Devices
Closed Bag/Line Access Devices
Closed Drug Transfer Systems Segment by Application
Hospital
Clinic
Closed Drug Transfer Systems Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Closed Drug Transfer Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Closed Drug Transfer Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Closed Drug Transfer Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Closed Drug Transfer Systems in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Closed Drug Transfer Systems industry.
Chapter 3: Detailed analysis of Closed Drug Transfer Systems companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Closed Drug Transfer Systemsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Closed Vial Access Devices
- Closed Syringe Safety Devices
- Closed Bag/Line Access Devices
Applications
- Hospital
- Clinic
Companies covered
- BD Medical, Inc
- Equashield, LLC
- ICU Medical, Inc
- Teva Medical Ltd
- Corvida Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Closed Drug Transfer Systems Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Closed Vial Access Devices
- 1.2.3 Closed Syringe Safety Devices
- 1.2.4 Closed Bag/Line Access Devices
- 1.3 Market Analysis by Application
- 1.3.1 Global Closed Drug Transfer Systems Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.4 Global Market Growth Prospects
- 1.5 Global Closed Drug Transfer Systems Growth Trends by Region
- 1.5.1 Global Closed Drug Transfer Systems Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Closed Drug Transfer Systems Market Size by Region (2021-2026)
- 1.5.3 Closed Drug Transfer Systems Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Closed Drug Transfer Systems Market Dynamics
- 2.1 Closed Drug Transfer Systems Industry Trends
- 2.2 Closed Drug Transfer Systems Industry Drivers
- 2.3 Closed Drug Transfer Systems Industry Opportunities and Challenges
- 2.4 Closed Drug Transfer Systems Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Closed Drug Transfer Systems Revenue by Company (2021-2026)
- 3.2 Global Closed Drug Transfer Systems Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Closed Drug Transfer Systems Key Company Head office and Area Served
- 3.4 Global Closed Drug Transfer Systems Company, Product Type & Application
- 3.5 Global Closed Drug Transfer Systems Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Closed Drug Transfer Systems Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Closed Drug Transfer Systems Players Market Share by Revenue in 2025
- 3.6.3 2025 Closed Drug Transfer Systems Tier 1, Tier 2, and Tier 3
4 Closed Drug Transfer Systems Market by Type
- 4.1 Global Closed Drug Transfer Systems Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Closed Drug Transfer Systems Market Size by Type (2021-2032)
- 4.3 Global Closed Drug Transfer Systems Market Size Share by Type (2021-2032)
5 Closed Drug Transfer Systems Market by Application
- 5.1 Global Closed Drug Transfer Systems Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Closed Drug Transfer Systems Market Size by Application (2021-2032)
- 5.3 Global Closed Drug Transfer Systems Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 BD Medical, Inc
- 6.1.1 BD Medical, Inc Company Information
- 6.1.2 BD Medical, Inc Business Overview
- 6.1.3 BD Medical, Inc Closed Drug Transfer Systems Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 BD Medical, Inc Closed Drug Transfer Systems Product Portfolio
- 6.1.5 BD Medical, Inc Recent Developments
- 6.2 Equashield, LLC
- 6.2.1 Equashield, LLC Company Information
- 6.2.2 Equashield, LLC Business Overview
- 6.2.3 Equashield, LLC Closed Drug Transfer Systems Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Equashield, LLC Closed Drug Transfer Systems Product Portfolio
- 6.2.5 Equashield, LLC Recent Developments
- 6.3 ICU Medical, Inc
- 6.3.1 ICU Medical, Inc Company Information
- 6.3.2 ICU Medical, Inc Business Overview
- 6.3.3 ICU Medical, Inc Closed Drug Transfer Systems Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 ICU Medical, Inc Closed Drug Transfer Systems Product Portfolio
- 6.3.5 ICU Medical, Inc Recent Developments
- 6.4 Teva Medical Ltd
- 6.4.1 Teva Medical Ltd Company Information
- 6.4.2 Teva Medical Ltd Business Overview
- 6.4.3 Teva Medical Ltd Closed Drug Transfer Systems Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Teva Medical Ltd Closed Drug Transfer Systems Product Portfolio
- 6.4.5 Teva Medical Ltd Recent Developments
- 6.5 Corvida Medical
- 6.5.1 Corvida Medical Company Information
- 6.5.2 Corvida Medical Business Overview
- 6.5.3 Corvida Medical Closed Drug Transfer Systems Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Corvida Medical Closed Drug Transfer Systems Product Portfolio
- 6.5.5 Corvida Medical Recent Developments
7 North America
- 7.1 North America Closed Drug Transfer Systems Market Size (2021-2032)
- 7.2 North America Closed Drug Transfer Systems Market Size by Type
- 7.2.1 North America Closed Drug Transfer Systems Market Size by Type (2021-2026)
- 7.2.2 North America Closed Drug Transfer Systems Market Size by Type (2027-2032)
- 7.2.3 North America Closed Drug Transfer Systems Market Share by Type (2021-2032)
- 7.3 North America Closed Drug Transfer Systems Market Size by Application
- 7.3.1 North America Closed Drug Transfer Systems Market Size by Application (2021-2026)
- 7.3.2 North America Closed Drug Transfer Systems Market Size by Application (2027-2032)
- 7.3.3 North America Closed Drug Transfer Systems Market Share by Application (2021-2032)
- 7.4 North America Closed Drug Transfer Systems Market Size by Country
- 7.4.1 North America Closed Drug Transfer Systems Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Closed Drug Transfer Systems Market Size by Country (2021-2026)
- 7.4.3 North America Closed Drug Transfer Systems Market Size by Country (2027-2032)
- 7.4.4 North America Closed Drug Transfer Systems Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Closed Drug Transfer Systems Market Size (2021-2032)
- 8.2 Europe Closed Drug Transfer Systems Market Size by Type
- 8.2.1 Europe Closed Drug Transfer Systems Market Size by Type (2021-2026)
- 8.2.2 Europe Closed Drug Transfer Systems Market Size by Type (2027-2032)
- 8.2.3 Europe Closed Drug Transfer Systems Market Share by Type (2021-2032)
- 8.3 Europe Closed Drug Transfer Systems Market Size by Application
- 8.3.1 Europe Closed Drug Transfer Systems Market Size by Application (2021-2026)
- 8.3.2 Europe Closed Drug Transfer Systems Market Size by Application (2027-2032)
- 8.3.3 Europe Closed Drug Transfer Systems Market Share by Application (2021-2032)
- 8.4 Europe Closed Drug Transfer Systems Market Size by Country
- 8.4.1 Europe Closed Drug Transfer Systems Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Closed Drug Transfer Systems Market Size by Country (2021-2026)
- 8.4.3 Europe Closed Drug Transfer Systems Market Size by Country (2027-2032)
- 8.4.4 Europe Closed Drug Transfer Systems Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Closed Drug Transfer Systems Market Size (2021-2032)
- 9.2 China Closed Drug Transfer Systems Market Size by Type
- 9.2.1 China Closed Drug Transfer Systems Market Size by Type (2021-2026)
- 9.2.2 China Closed Drug Transfer Systems Market Size by Type (2027-2032)
- 9.2.3 China Closed Drug Transfer Systems Market Share by Type (2021-2032)
- 9.3 China Closed Drug Transfer Systems Market Size by Application
- 9.3.1 China Closed Drug Transfer Systems Market Size by Application (2021-2026)
- 9.3.2 China Closed Drug Transfer Systems Market Size by Application (2027-2032)
- 9.3.3 China Closed Drug Transfer Systems Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Closed Drug Transfer Systems Market Size (2021-2032)
- 10.2 Asia Closed Drug Transfer Systems Market Size by Type
- 10.2.1 Asia Closed Drug Transfer Systems Market Size by Type (2021-2026)
- 10.2.2 Asia Closed Drug Transfer Systems Market Size by Type (2027-2032)
- 10.2.3 Asia Closed Drug Transfer Systems Market Share by Type (2021-2032)
- 10.3 Asia Closed Drug Transfer Systems Market Size by Application
- 10.3.1 Asia Closed Drug Transfer Systems Market Size by Application (2021-2026)
- 10.3.2 Asia Closed Drug Transfer Systems Market Size by Application (2027-2032)
- 10.3.3 Asia Closed Drug Transfer Systems Market Share by Application (2021-2032)
- 10.4 Asia Closed Drug Transfer Systems Market Size by Country
- 10.4.1 Asia Closed Drug Transfer Systems Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Closed Drug Transfer Systems Market Size by Country (2021-2026)
- 10.4.3 Asia Closed Drug Transfer Systems Market Size by Country (2027-2032)
- 10.4.4 Asia Closed Drug Transfer Systems Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Closed Drug Transfer Systems Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Closed Drug Transfer Systems Market Size by Type
- 11.2.1 South America, Middle East & Africa Closed Drug Transfer Systems Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Closed Drug Transfer Systems Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Closed Drug Transfer Systems Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Closed Drug Transfer Systems Market Size by Application
- 11.3.1 South America, Middle East & Africa Closed Drug Transfer Systems Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Closed Drug Transfer Systems Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Closed Drug Transfer Systems Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Closed Drug Transfer Systems Market Size by Country
- 11.4.1 South America, Middle East & Africa Closed Drug Transfer Systems Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Closed Drug Transfer Systems Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Closed Drug Transfer Systems Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Closed Drug Transfer Systems Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst